Skip to main content

Day: December 26, 2023

Antibiotics Market Size Worth USD 71.75 Billion in 2032 | Emergen Research

Increasing rate of infectious diseases, development of innovative products, and rising usage of antibiotics are major factors driving Antibiotics Market revenue growth Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global antibiotics market size was USD 42.32 Billion in 2022 and is expected to register a rapid revenue CAGR of 5.5% during the forecast period. The global antibiotics market is witnessing significant growth, driven by factors such as the increasing rate of infectious diseases, development of innovative products, and rising antibiotic usage. A study published in September 2022 by the Lancet Regional Health-Southeast Asia revealed that azithromycin 500mg tablets were the most frequently used antibiotics in India. However, despite this growth, challenges like antibiotic resistance and high research costs pose potential...

Continue reading

Photopolymers Market Size Worth USD 7.08 Billion in 2032 | Emergen Research

Riding demand for Three Dimensional (3D) Printing is a key factor driving Photopolymers Market revenue growth Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global photopolymers market size was USD 2.60 Billion in 2022 and is expected to register a steady revenue CAGR of 10.5% during the forecast period, according to latest analysis by Emergen Research. Rising demand for 3D printing, technological advancements in the printing and packaging industry, and increasing need for artificial jewelry and prosthetics globally are key factors driving market revenue growth. Photopolymers are one of the materials used in 3D printing with the potential to make products with better properties. The field of 3D printing is rapidly growing in both academic and commercial settings. Photopolymerization-based technologies (such as Stereolithography...

Continue reading

Global Electrosurgical Products Market Size to Reach USD 14.99 Billion in 2032 | Emergen Research

Increasing number of minimally invasive surgical procedures is a major factor driving Electrosurgical Products market revenue growth Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global electrosurgical products market size was USD 8.90 Billion in 2022 and is expected to register a steady revenue CAGR of 5.3% during the forecast period, according to latest analysis by Emergen Research. Increasing number of minimally invasive surgical procedures is a key factor driving market revenue growth. Many healthcare institutions and professionals are becoming more environmentally conscious, and there is an increasing emphasis on Corporate Social Responsibility (CSR). Electrosurgical products are used in surgical procedures, such as cardiovascular surgery, gynecology surgery, general surgery, and others, which apply electric current for...

Continue reading

Global Bottled Water Market Size to Reach USD 593.02 Billion in 2032 | Emergen Research

Rising concerns over quality and safety of tap water is a major factor driving Bottled Water market revenue growth Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global bottled water market size was USD Billion 303.56 in 2022 and is expected to register a revenue CAGR of 7.0% during the forecast period, according to the latest analysis by Emergen Research. Increasing knowledge of value of staying hydrated and living healthy is a major factor expected to drive market revenue growth during the forecast period. The bottled water sector fits into sustainable development aim of providing everyone with access to clean water. The investigation only considered bottled water brands that taste nearly identical to tap water obtained from a standard municipal water supply. It is demonstrated that water in bottles is commonly used in both...

Continue reading

Intra-Oral Flat Panel Sensor Market Size to Reach USD 500 Million in 2032 | Emergen Research

Rising demand for intra-oral flat panel sensors in dental imaging is a key factor driving Intra-Oral Flat Panel Sensor market revenue growth Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global intra-oral flat panel sensor market size was USD 337 Million in 2022 and is expected to register a steady revenue CAGR of 4% during the forecast period, according to latest analysis by Emergen Research. Rising demand for intra-oral flat panel sensors in dental imaging is a key factor driving market revenue growth. Intra-oral flat panel sensors are critical diagnostic components that are designed to be placed within the patient’s oral cavity. These sensors can collect very detailed images that provide the dentist with crucial diagnostic information. In addition, increasing use of dental imaging technology due to rising prevalence...

Continue reading

Inductive Encoder Market Growth CAGR 8.3% During 2022-2032 | Emergen Research

Rising demand for inductive encoders in industrial automation is a major factor driving the Inductive Encoder market revenue growth. Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) — The global inductive encoder market size was USD billion in 2022 and is expected to register a revenue CAGR of 8.3% during the forecast period, according to the latest analysis by Emergen Research. Increasing adoption of inductive encoders in industrial automation equipment such as robotic arms, actuators, conveyors, and other moving components are driving market revenue growth.Inductive encoder is designed to detect accurate, precise, and calibrated positions. Globally, an array of industries is adopting the industry ‘4.0’ paradigm, which frames development of various digital technologies as the fourth industrial revolution. Modern industrial...

Continue reading

Global Power Steering Pump Market Size Worth USD 5.02 Billion in 2032 | Emergen Research

Increasing focus on considering enhanced Noise, Vibration, and Harshness (NVH) control and integration of sensor technologies is a major factor driving the Power Steering Pump market revenue growth. Vancouver, Dec. 26, 2023 (GLOBE NEWSWIRE) —  The global power steering pump market size was USD 1.74 Billion in 2022 and is expected to register a revenue CAGR of 3.1% during the forecast period, according to latest analysis by Emergen Research. Increasing focus on considering enhanced Noise, Vibration, and Harshness (NVH) control in power steering pump design is a major factor driving the market revenue growth. Manufacturers are employing advanced techniques, such as improved pump rotor profiles, vibration-dampening technologies, and noise reduction measures, to minimize noise and vibration levels. This ensures a smoother and quieter...

Continue reading

SEALSQ Appoints Vice President of Global Sales

Tortola, British Virgin Islands, Dec. 26, 2023 (GLOBE NEWSWIRE) — SEALSQ Appoints Vice President of Global Sales December 26, 2023: SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, today announced the appointment of Franck Buonanno as Vice President of Global Sales for its Semiconductor and PKI activities, effective immediately. Mr. Buonanno joined WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN; Nasdaq: WKEY), SEALSQ’s parent company, in August 2021 as Director of Sales for Europe. In his new role as Vice President of Global Sales for SEALSQ, Mr. Buonanno will be responsible for leading the Company’s global sales efforts. With a career spanning three decades...

Continue reading

iBio Amends and Extends Maturity of Credit Agreement

– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business – BRYAN, Texas and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced its wholly owned subsidiary, iBio CDMO LLC, and its lender, Woodforest National Bank (“Woodforest”), have entered into an amendment (the “Amendment”) to the Credit Agreement dated November 1, 2021 (the “Agreement”), extending the Agreement’s maturity date from December 31, 2023 to the earlier March 29, 2024, or the acceleration of maturity of the term loan in accordance with the Credit Agreement. “We are pleased to have worked constructively with Woodforest to execute this amendment and extension of the maturity...

Continue reading

Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio

Transaction Brings RayzeBio’s Differentiated Actinium-Based Radiopharmaceutical Platform, Including Rich Pipeline of Multiple Drug Development Programs to Bristol Myers Squibb’s Leading Oncology Franchise Lead Program, RYZ101, in Phase 3 Development for Treatment of Gastroenteropancreatic Neuroendocrine Tumors and Early-stage Development for Treatment of Small Cell Lung Cancer and Potentially Other Tumor Types Gains Robust IND Engine and State of the Art Radiopharmaceutical Manufacturing Capabilities PRINCETON, N.J. and SAN DIEGO, Dec. 26, 2023 (GLOBE NEWSWIRE) — Bristol Myers Squibb (NYSE: BMY) and RayzeBio, Inc. (NASDAQ: RYZB) today announced a definitive merger agreement under which Bristol Myers Squibb will acquire RayzeBio for $62.50 per share in cash, for a total equity value of approximately $4.1 billion, or $3.6 billion...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.